MétaCan
Menu
Back to cohort
Record W4246880258 · doi:10.1136/gut.2011.239301.328

Efficacy of antidepressants in irritable bowel syndrome: an updated systematic review and meta-analysis controlling for depression

2011· article· en· W4246880258 on OpenAlexaff
Alexander C. Ford, Nicholas J. Talley, Paul Moayyedi

Bibliographic record

VenueGut · 2011
Typearticle
Languageen
FieldMedicine
TopicGastrointestinal motility and disorders
Canadian institutionsMcMaster University
Fundersnot available
KeywordsMedicineIrritable bowel syndromePlaceboMeta-analysisInternal medicineRandomized controlled trialDepression (economics)Subgroup analysisPsychiatryAlternative medicine

Abstract

fetched live from OpenAlex

Introduction Antidepressants may be effective for the treatment of irritable bowel syndrome, but some experts are sceptical, and effect of co-existent depression has not been controlled for in previous meta-analyses. We updated a previous systematic review to estimate their efficacy in the treatment of IBS and examine this issue. Methods MEDLINE, EMBASE and the Cochrane Controlled Trials Register were searched (up to November 2010) to identify randomised controlled trials (RCTs) comparing antidepressants with placebo in adult IBS patients. Subjects were required to be followed up for at least 1 week, and studies had to report either a global assessment of IBS symptom cure or improvement, or abdominal pain cure or improvement, after completion of therapy. Data were extracted as intention-to-treat analyses with drop-outs assumed to be treatment failures, and pooled using a random effects model. Effect of antidepressants compared to placebo was reported as the relative risk (RR) of remaining symptomatic, with a 95% CI. Trials that screened for and excluded depressed individuals were pooled separately in a subgroup analysis. Results 16 RCTs were eligible for inclusion, including 1022 patients, 554 of whom received antidepressants and 468 placebo. Nine RCTs used tricyclic antidepressants (TCAs), six RCTs selective serotonin reuptake inhibitors (SSRIs), and one RCT both. There were 242 (43.7%) patients assigned to antidepressant therapy with persistent or unimproved IBS symptoms following therapy, compared to 314 (64.9%) allocated to placebo (RR of IBS symptoms persisting = 0.67; 95% CI 0.56 to 0.78). When the 10 RCTs of TCAs were pooled, 166 (43.9%) of 378 had persistent symptoms, compared to 189 (62.2%) of 304 receiving placebo (RR = 0.70; 95% CI 0.60 to 0.83). In the five RCTs of SSRIs 76 (43.2%) of 176 patients allocated to SSRIs had persistent symptoms, compared to 125 (69.4%) of 180 placebo patients (RR = 0.63; 95% CI 0.44 to 0.91). When only the four RCTs that screened for and excluded depressed individuals were included in the analysis RR of symptoms persisting was 0.73 (95% CI 0.47 to 1.15), compared with a RR of 0.65 (95% CI 0.55 to 0.78) in the other 12 trials. However, this difference was not statistically significant (Cochrane Q = 0.64). Conclusion Evidence continues to accumulate for the efficacy of antidepressants in the treatment of IBS. However, part of their beneficial effect may stem from the treatment of co-existent depression. More RCTs examining their efficacy in non-depressed IBS patients are required to clarify this issue.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Meta-analysis · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.681
Threshold uncertainty score0.355

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0020.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.076
GPT teacher head0.315
Teacher spread0.239 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designMeta-analysis
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2011
Admission routes1
Has abstractyes

Explore more

Same venueGutSame topicGastrointestinal motility and disordersFrench-language works237,207